Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TW vs Valsartan in Membranous Nephropathy
NCT00518219Phase 4Completed
- Sponsor
- Nanjing University School of Medicine
- Start
- Jul 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Tripterygium wilfordii in membranous nephropathy (MN), sponsored by Nanjing University School of Medicine. Started Jul 2007; status: completed.
02
Drugs
Tripterygium wilfordii
03
Conditions
membranous nephropathy (MN)
Beyond the preview
Go deeper on NCT00518219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518219.